drugset / Trial / NCT02809261

The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome

NCT02809261 ↗

Completed 60 enrolled Tri-Service General Hospital (TSGH)
RandomizedParallel-groupDouble-blindTreatment

Summary

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. Although many conservative managements of CTS, the effectiveness of these methods is insignificant or only persist for a short duration. Recently, the ultrasound-guided perineural injection with 5% dextrose was widely used for entrapment neuropathy with positive benefit. However, current studies have not entirely proved the effects of perineural injection on peripheral neuropathy because these studies enrolled small number of patients and lacked controlled design. The investigators design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided perineural injection with 5% dextrose in patients with CTS.

Timeline

Start
2016-05-01
Primary completion
2017-03-30
Completion
2017-03-30

Outcome

Met primary endpoint

paper Compared with the control group, at all post-injection time points, the D5W group had a significant reduction in pain and disability PMID 28778254 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 3 ml Other